Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Epigenetic modifications, including DNA methylation, histone modifications, and microRNAs, are linked to tumor development.
• These epigenetic changes can influence autophagy, a cellular process crucial for tumor progression.
• Epigenetic regulators impact tumor-associated gene expression and autophagy.

Purpose of the Study:

• To review the role of epigenetic modification in autophagy during tumorigenesis.
• To elucidate the molecular mechanisms linking epigenetics, autophagy, and cancer.
• To summarize the efficacy of epigenetic drugs in modulating autophagy for cancer therapy.

Main Methods:

• Literature review and synthesis of existing evidence.
• Analysis of molecular mechanisms.
• Summary of preclinical and clinical findings on epigenetic drugs targeting autophagy.

Main Results:

• Epigenetic modifications directly and indirectly regulate autophagy in tumors.
• Tumor-associated microRNAs play a significant role in autophagy during cancer progression.
• Epigenetic drugs show potential in modulating autophagy for therapeutic benefit.

Conclusions:

• Epigenetic modifications are key regulators of autophagy in cancer.
• Targeting autophagy via epigenetic drugs presents a viable therapeutic avenue for human tumors.
• Combined treatment strategies involving epigenetic drugs and autophagy mediators warrant further investigation.